Newsroom
A team of researchers from the University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical, and Vanderbilt University have developed an antibody treatment that successfully protected nonhuman primates against the deadly Marburg and Ravn viruses, relatives of Ebola, even when administered five days after infection.
Read More
A multidisciplinary team from the University of Texas Medical Branch at Galveston has uncovered the mechanisms that the Zika virus uses to alter brain development. There are currently 70 countries and territories reporting active Zika transmission, according to the World Health Organization. While a Zika infection typically results in mild or symptom-free infections in healthy adults and children, the risk of microcephaly in the developing fetus is an alarming consequence that has created a worldwide health threat.
Read More
To help stop the spread of diseases carried by arthropod vectors such as mosquitoes and ticks, the Centers for Disease Control and Prevention awarded $10 million to The University of Texas Medical Branch at Galveston to establish the Western Gulf Center fo Excellence for Vector-Borne Diseases. The Center's work will protect public health in the region, the nation and beyond.
Read More
The Galveston National Lab is a global resource, training students, researchers and government policy leaders, UTMB’s James Le Duc told The Daily News. “This is a pipeline getting into the national leaders of the next generation,” Le Duc said. “It’s a very, very important role.”
Read More
Thanks to a $1.3 million agreement, researchers from UTMB’s National Biocontainment Training Center will embark on a two-year research development program to collaborate with and help train Cuban scientists at the Instituto Pedro Kouri in Havana to better fight infectious diseases, including the Zika virus, which is currently infecting millions internationally.
Read More